SIRT1 promotes macrophage polarization to enhance efferocytosis by regulating TXNIP/NLRP3 inflammasome pathway

Tongda Xu,Hong Zhu,Buchun Zhang,Ya-Hui Ma,Qiao Jiang,Dongye Li,Yang Liu
DOI: https://doi.org/10.21203/RS.3.RS-198697/V1
2021-02-23
Abstract:Objects: This study aimed to determine if SIRT1couldenhance efferocytosis and inhibit apoptosis by modulating cell polarization through the TXNIP/NLRP3 inflammasome pathway in murine peritoneal macrophages.Methods and Results: The effects of SIRT1in peritoneal macrophages were detected using adenovirus-mediated overexpression and knockdown of SIRT1. The apoptotic rate was determined by Annexin V/propidium iodide staining. LDLcholesterol levels were tested by Oil Red O staining and cholesterol testing. Efferocytosisof peritoneal macrophages was determined by fluorescence staining and macrophage markers were determined by flow cytometry, western blot, and ELISA.SIRT1 decreased cholesterol intake andthe apoptotic rate stimulated with ox-LDL in macrophages, which was consistent with upregulation of Bcl-2 and caspase-3 and downregulation of Bax and cleaved caspase-3. SIRT1 increased efferocytosis in macrophages. Expression levels of the M1 macrophage markers IL-6, TNF-α, iNOS, and CD16/32 were decreased, and levels of the M2 markers Dectin-1, IL-10, Arg-1, and CD206 were increased by SIRT1. Moreover, SIRT1 inhibited the ox-LDL stimulated increase in expression of TXNIP and NLRP3 proteins. The effects of SIRT1 were similar to those of TXNIP/NLRP3 inflammasome pathway inhibitor MCC950.Conclusions: These results indicated that SIRT1 exerted an anti-atherosclerosis effect by regulating macrophage polarization to enhance efferocytosis and inhibit apoptosis. Specifically, these effects were generated by downregulation of the TXNIP/NLRP3inflammasome pathway.
Medicine,Biology,Chemistry
What problem does this paper attempt to address?